CellaVision AB (publ)

kr 199.00As of Sun 8 Nov 2026, 12:00 UTC
STO:CEVIHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 10.23%
Div yield 1.38%
ROE 15.45%
Medical Devices
Beta (5Y) 0.87
PE TTM 34.42
TSR TTM 13.01%
Mkt cap kr 4.746B
ROIC 18.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 247
24.26%
(11.25%)
Hold 0|9|1|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
3.87
4.32
4.46
4.38
23.24%
29.23%
20.26%
21.19%
Revenuekr M
252.0
262.2
259.7
259.6
6.81%
7.47%
2.80%
1.06%
Peers (US$479.9M)
Cap (US$)
PE
849.4M
30.65x
629.0M
48.29x
Capital
TTM
5Y
10Y
Leveragex
3.299
0.247
0.240
EBIT/Intx
2.560
0.826
0.784
Own earn%
(82.85)
(65.52)
(101.59)
Sh yield%
31.67
13.56
14.27
Owners
Insiders/Inst%
14.54
37.30
Short interest%
1.60
SBC / revenue%
1.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
13–24
$1 testx
0.0
Incr. ROIC%
18